Skip to content
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Pediatric Endocrinology

Understanding Your Baby's Diagnosis: Dyshormonogenic Goiter

At a Glance

Dyshormonogenic goiter is a form of congenital hypothyroidism in which a baby's thyroid is present but cannot make enough hormone. Prompt levothyroxine treatment and regular blood tests support healthy brain development and growth; some DUOX2-related forms may be temporary.

Receiving an abnormal newborn screening result can be an overwhelming experience that sparks immediate worry. It is important to know that you are not alone in this; while the diagnosis of dyshormonogenic goiter sounds complex, it is a well-understood cause of congenital hypothyroidism (an underactive thyroid present from birth) [1][2].

The most vital thing to understand right now is that this condition is highly treatable. When babies begin treatment promptly, they typically grow and develop just as well as any other child [3][4].

What is Dyshormonogenic Goiter?

To understand this condition, it helps to break down the name. A goiter is simply an enlarged thyroid gland [5]. Dyshormonogenic means the “machinery” inside the thyroid gland that makes hormones is not working correctly [1].

Think of the thyroid like a factory. In most cases of congenital hypothyroidism, the factory was never built or was built in the wrong place. In dyshormonogenic goiter, the factory is in the right place and may even be larger than normal, but the assembly line inside is broken [5][6]. Because the body senses there isn’t enough thyroid hormone, it sends signals to the “factory” to work harder, which can cause the gland to grow—creating a goiter [7].

How Common Is It?

Congenital hypothyroidism occurs in approximately 1 in 2,000 to 4,000 newborns worldwide [8][9]. Dyshormonogenic goiter accounts for about 10% to 15% of these cases globally, though in some regions or specific populations, it can account for 40% or even up to 60% of cases [1][2][10].

Why Your Baby Looks “Normal”

It is perfectly normal if your baby looks and acts healthy right now. Most newborns with this condition show no outward signs at birth [11]. While the term “goiter” might make you worry about a large, visible mass on your baby’s neck, this is rarely the case in newborns. In fact, many goiters are only detectable through a thyroid ultrasound (an imaging test using sound waves) and cannot be seen or felt by hand [5].

If symptoms do appear early on, they are often subtle and non-specific, such as:

  • Jaundice (a yellowing of the skin or eyes) that lasts longer than usual [11][4].
  • Being extra sleepy or having low energy [4].
  • Constipation [4].
  • Difficulty staying warm [4].

The Importance of Early Treatment

The goal of treatment is to replace the hormone your baby’s thyroid isn’t making enough of. This is done with a daily medication called levothyroxine, which is a synthetic version of the natural thyroid hormone [12].

  • Prompt Start: Starting medication as soon as the diagnosis is confirmed is the most important step for protecting your baby’s brain development [12][13].
  • Normal Outcomes: When treatment is started early and the hormone levels are kept in the target range, children typically meet all their developmental milestones and lead healthy lives [3][4].
  • Goiter Management: Taking the medication correctly often helps the thyroid gland shrink back to a more normal size over time [7][14].

Is This Permanent?

In many cases, this condition is lifelong because it is caused by a permanent genetic change in how the thyroid functions [1][15]. However, some forms (specifically those related to a gene called DUOX2) can sometimes be transient, meaning the thyroid may eventually start working on its own [3][16].

If the endocrinologist suspects a transient form, doctors may wait until a child is about 3 years old before testing to see if the condition is permanent. At that age, the brain is developed enough that it is safer to briefly pause the medication under strict medical supervision to see if the body can maintain its own hormone levels. This trial is not required for every child and must be physician-led [17][18].

What to Expect in the First Month

Your care team will guide you through a typical first-month sequence, which includes:

  1. Confirmatory Blood Tests: To double-check the newborn screening results with a standard blood draw [19].
  2. Immediate Medication: Starting levothyroxine right away.
  3. Early Check: Your first follow-up blood test about 1 to 2 weeks after starting medication to ensure levels are improving.
  4. Imaging (if directed): An ultrasound or a scintigraphy (a specialized scan) to look at the size and shape of the thyroid, though treatment never waits for this [20].
  5. Frequent Monitoring: Ongoing blood tests during the first few years of life to ensure your baby’s medication dose is adjusted as they grow [19][4].

While the diagnosis is a lot to process, the medical community has excellent systems in place to support your family. Your proactive steps now are ensuring your baby has the best possible start in life [12].

Common questions in this guide

What does dyshormonogenic goiter mean in a newborn?
Dyshormonogenic goiter is an enlarged or potentially enlarged thyroid gland that cannot make enough thyroid hormone. This causes congenital hypothyroidism even though the thyroid is in its usual place and may look normal from the outside.
Can my baby have dyshormonogenic goiter and still look healthy?
Yes. Most newborns have no obvious signs, and thyroid enlargement may be detectable only with an ultrasound. If symptoms occur, they can be subtle, such as prolonged jaundice, sleepiness, constipation, or trouble staying warm.
How is dyshormonogenic goiter confirmed after an abnormal newborn screen?
Doctors usually confirm the screening result with blood tests. They may also use an ultrasound or a specialized thyroid scan to assess the gland, but levothyroxine treatment should not be delayed while waiting for imaging.
What treatment does a baby with dyshormonogenic goiter need?
Treatment is daily levothyroxine, a synthetic form of thyroid hormone. Starting it promptly and checking blood levels regularly supports healthy brain development and growth, while the dose is adjusted as the baby grows. Taking the medicine correctly may also help an enlarged thyroid shrink.
Will my baby's dyshormonogenic goiter last for life?
Many cases are lifelong because they result from a genetic change affecting thyroid hormone production. Some DUOX2-related forms can be temporary, so an endocrinologist may consider supervised testing after a medication pause around age 3. Families should never stop treatment without medical direction.
What happens during the first month after my baby is diagnosed?
Your baby will usually start levothyroxine after confirmatory testing, have blood levels checked about 1 to 2 weeks later, and continue with regular monitoring. An ultrasound or specialized scan may be ordered to examine the thyroid, but imaging does not replace prompt treatment.
Can early treatment help my baby develop normally?
With prompt treatment and thyroid hormone levels kept in the recommended range, children with dyshormonogenic goiter typically grow and meet developmental milestones normally. Ongoing blood tests help the care team adjust the dose as the child grows.

Get notified when new evidence is published on dyshormonogenic goiter.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (20)
  1. 1

    Clinical genetics of defects in thyroid hormone synthesis.

    Kwak MJ

    Annals of pediatric endocrinology & metabolism 2018; (23(4)):169-175 doi:10.6065/apem.2018.23.4.169.

    PMID: 30599477
  2. 2

    Next-Generation Sequencing Analysis Reveals Frequent Familial Origin and Oligogenism in Congenital Hypothyroidism With Dyshormonogenesis.

    Oliver-Petit I, Edouard T, Jacques V, et al.

    Frontiers in endocrinology 2021; (12()):657913 doi:10.3389/fendo.2021.657913.

    PMID: 34248839
  3. 3

    Natural course of congenital hypothyroidism by dual oxidase 2 mutations from the neonatal period through puberty.

    Maruo Y, Nagasaki K, Matsui K, et al.

    European journal of endocrinology 2016; (174(4)):453-63 doi:10.1530/EJE-15-0959.

    PMID: 26742565
  4. 4

    Congenital Hypothyroidism: Screening and Management.

    Rose SR, Wassner AJ, Wintergerst KA, et al.

    Pediatrics 2023; (151(1)) doi:10.1542/peds.2022-060420.

    PMID: 36827521
  5. 5

    Mutation screening of eight genes and comparison of the clinical data in a Chinese cohort with congenital hypothyroidism.

    Li L, Li X, Wang X, et al.

    Endocrine 2023; (79(1)):125-134 doi:10.1007/s12020-022-03188-4.

    PMID: 36125728
  6. 6

    Double variants in TSHR and DUOX2 in a patient with hypothyroidism: case report.

    Sasivari Z, Szinnai G, Seebauer B, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2019; (32(11)):1299-1303.

    PMID: 31541602
  7. 7

    Permanent Congenital Hypothyroidism due to Rare Thyroglobulin Gene Variant (p.Cys1476Arg): A Delayed Diagnosis of Thyroid Dyshormonogenesis.

    Mohamadsalih G, Al Bureshad K, Mohammed I, et al.

    Case reports in medicine 2025; (2025()):5313611 doi:10.1155/carm/5313611.

    PMID: 40453448
  8. 8

    Congenital hypothyroidism due to thyroglobulin deficiency: a case report with a novel mutation in TG gene.

    Heo S, Jang JH, Yu J

    Annals of pediatric endocrinology & metabolism 2019; (24(3)):199-202 doi:10.6065/apem.2019.24.3.199.

    PMID: 31607114
  9. 9

    Molecular Analysis of Congenital Hypothyroidism in Saudi Arabia: SLC26A7 Mutation Is a Novel Defect in Thyroid Dyshormonogenesis.

    Zou M, Alzahrani AS, Al-Odaib A, et al.

    The Journal of clinical endocrinology and metabolism 2018; (103(5)):1889-1898 doi:10.1210/jc.2017-02202.

    PMID: 29546359
  10. 10

    Increased Prevalence of TG and TPO Mutations in Sudanese Children With Congenital Hypothyroidism.

    Bruellman RJ, Watanabe Y, Ebrhim RS, et al.

    The Journal of clinical endocrinology and metabolism 2020; (105(5)) doi:10.1210/clinem/dgz297.

    PMID: 31867598
  11. 11

    Genetic Factors Causing Thyroid Dyshormonogenesis as the Major Etiologies for Primary Congenital Hypothyroidism: Clinical and Genetic Characterization of 33 Patients.

    Liu R, Tian JL, Huang XL, Song YZ

    Journal of clinical medicine 2022; (11(24)) doi:10.3390/jcm11247313.

    PMID: 36555929
  12. 12

    Congenital Hypothyroidism: A 2020-2021 Consensus Guidelines Update-An ENDO-European Reference Network Initiative Endorsed by the European Society for Pediatric Endocrinology and the European Society for Endocrinology.

    van Trotsenburg P, Stoupa A, Léger J, et al.

    Thyroid : official journal of the American Thyroid Association 2021; (31(3)):387-419 doi:10.1089/thy.2020.0333.

    PMID: 33272083
  13. 13

    Congenital Hypothyroidism.

    Wassner AJ

    Clinics in perinatology 2018; (45(1)):1-18 doi:10.1016/j.clp.2017.10.004.

    PMID: 29405999
  14. 14

    A novel homozygous thyroglobulin gene variant presenting with massive congenital goiter and neonatal airway obstruction.

    Anık A, Şen Küçük K, Öztürk S, et al.

    Hormones (Athens, Greece) 2026; doi:10.1007/s42000-026-00810-2.

    PMID: 42463600
  15. 15

    Clinical efficacy of multigene panels in the management of congenital hypothyroidism with gland in situ.

    Park J, Joo EY, Yoo MJ, et al.

    Medicine 2024; (103(29)):e38976 doi:10.1097/MD.0000000000038976.

    PMID: 39029043
  16. 16

    DUOX Defects and Their Roles in Congenital Hypothyroidism.

    De Deken X, Miot F

    Methods in molecular biology (Clifton, N.J.) 2019; (1982()):667-693 doi:10.1007/978-1-4939-9424-3_37.

    PMID: 31172499
  17. 17

    MECHANISMS IN ENDOCRINOLOGY: The pathophysiology of transient congenital hypothyroidism.

    Peters C, Schoenmakers N

    European journal of endocrinology 2022; (187(2)):R1-R16 doi:10.1530/EJE-21-1278.

    PMID: 35588090
  18. 18

    The evaluation of transient hypothyroidism in patients diagnosed with congenital hypothyroidism.

    Peltek Kendirci HN, Aycan Z, Sağsak E, et al.

    Turkish journal of medical sciences 2015; (45(4)):745-50.

    PMID: 26422840
  19. 19

    Newborn Screening Guidelines for Congenital Hypothyroidism in India: Recommendations of the Indian Society for Pediatric and Adolescent Endocrinology (ISPAE) - Part II: Imaging, Treatment and Follow-up.

    Sudhanshu S, Riaz I, Sharma R, et al.

    Indian journal of pediatrics 2018; (85(6)):448-453 doi:10.1007/s12098-017-2576-x.

    PMID: 29455331
  20. 20

    Iodide handling disorders (NIS, TPO, TG, IYD).

    Targovnik HM, Citterio CE, Rivolta CM

    Best practice & research. Clinical endocrinology & metabolism 2017; (31(2)):195-212 doi:10.1016/j.beem.2017.03.006.

    PMID: 28648508

This page is for informational purposes only and does not constitute medical advice. Your baby's pediatric endocrinologist should interpret test results and guide treatment, including any medication changes.